Download PDF
Horm Metab Res 2005; 37(5): 286-289
DOI: 10.1055/s-2005-861472
Original Clinical
© Georg Thieme Verlag KG Stuttgart · New York

Dopaminergic Influence on Thyrotropin Secretion in Primary Hypothyroidism

S.  Reddy1 , A.  Bhansali1 , R.  Sialy1 , S.  Masoodi1 , P.  Dutta1 , S.  Bhadada1 , R.  Dash1
  • 1 Department of Endocrinology and Metabolism, Postgraduate Institute of Medical Education & Research, Chandigarh, India
Further Information

Publication History

Received 29 June 2004

Accepted after second revision 15 December 2004

Publication Date:
22 June 2005 (online)

Also available at
    Permissions and Reprints

Abstract

This study was conducted to assess the influence of dopamine on thyrotropin secretion in patients with primary hypothyroidism before and after optimized L-thyroxin replacement therapy. Thyrotropin responses to dopamine infusion (4 µg/kg/min over 3 hours) and IV metoclopramide (10 mg bolus), a dopamine receptor blocker were studied in 25 consecutive patients with primary hypothyroidism before and after achieving stable euthyroid state and compared with 15 normal age-matched controls. Thyrotropin response to both dopamine infusion (decremental) and IV metoclopramide bolus (incremental) was greater in patients with primary hypothyroidism than that in the control subjects. Thyrotropin response was greater in women than in men. The magnitude of decremental thyrotropin response to dopamine infusion and the incremental response to IV metoclopramide bolus significantly correlated with the basal T3 and T4 levels. Thyrotropin response was blunted to dopamine infusion but not to metoclopramide at follow-up after six-month replacement with L-thyroxin, and both the responses were comparable in women and men in patient group. We conclude that modulation of dopaminergic system by dopamine or by dopamine receptor blocker has a greater influence on thyrotropin secretion in patients with primary hypothyroidism than euthyroid normal subjects.

Key words

Dopamine - Metoclopramide - Primary hypothyroidism - Thyrotropin

References

  • 1 Jackson I M. Thyrotropin-releasing hormone.  N Engl J Med. 1982;  306 145-155
    PubMedGoogle Scholar
  • 2 Oppenheimer J H, Schwartz H L, Mariash C N, Kinlaw W B, Wong N CW, Freake H C. Advances in understanding of thyroid hormone action at the cellular level.  Endocr Rev. 1987;  8 288-308
    CrossrefPubMedGoogle Scholar
  • 3 Lamberts S WJ, Zuyderwijk J, den Holder F, Koetsveld P V, Hofland L. Studies on the condition determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells.  Neuroendocrinology. 1989;  50 44-50
    PubMedGoogle Scholar
  • 4 Dieguez C, Foord S M, Peters J R, Hall R, Scanlon M F. Interactions among epinephrine, thyrotropin-releasing hormone, dopamine and somatostatin in the control of TSH secretion in vitro.  Endocrinology. 1984;  114 957-961
    PubMedGoogle Scholar
  • 5 Klibanski A, Milbury P E, Chin W W, Ridgway E C. Direct adrenergic stimulation of the release of thyrotropin and its subunits from the thyrotroph in vitro.  Endocrinology. 1983;  113 1244-1249
    PubMedGoogle Scholar
  • 6 Foord S M, Peters J, Scanlon M F, Rees Smith B, Hall R. Dopaminergic control of TSH secretion in isolated rat pituitary cells.  FEBS Lett. 1980;  121 257-259
    CrossrefPubMedGoogle Scholar
  • 7 Foord S M, Peters J R, Dieguez C, Shewring G, Hall R, Scanlon M F. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.  Endocrinology. 1986;  118 1319-1326
    PubMedGoogle Scholar
  • 8 Chen H J, Meites J. Effects of biogenic amines and TRH on release of prolactin and TSH in the Rat.  J Clin Endocrinol Metab. 1975;  96 10-14
    PubMedGoogle Scholar
  • 9 Feek C M, Sawers J SA, Brown N S, Seth J, Irvine W J, Toft A D. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion.  J Clin Endocrin Metab. 1980;  51 585-589
    PubMedGoogle Scholar
  • 10 Rapoport B, Refetoff S, Fang V S, Friesen H G. Suppression of serum thyrotropin (TSH) by L-Dopa in chronic hypothyroidism.  J Clin Endocrinol Metab. 1973;  36 256-262
    PubMedGoogle Scholar
  • 11 Leblanc H, Lachelin G CL, Abu-Fadil S, Yen S SC. Effect of dopamine infusion on pituitary hormone secretion in humans.  J Clin Endocrinol Metab. 1976;  43 668-674
    PubMedGoogle Scholar
  • 12 Burrow G N, May P B, Spaulding S W, Donabedian R K. TRH and dopamine interactions affecting pituitary hormone secretion.  J Clin Endocrinol Metab. 1977;  45 65-67
    PubMedGoogle Scholar
  • 13 Besses G S, Burrow G N, Spaulding S W, Donabedian R K. Dopamine infusion acutely inhibits the TSH and Prolactin response to TRH.  J Clin Endocrinol Metab. 1975;  41 985-987
    PubMedGoogle Scholar
  • 14 Zulewski H, Muller B, Exer P, Andre R, Staub J J. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of Patients with various grades of Hypothyroidism and controls.  J Clin Endocrinol Metab. 1997;  82 771- 776
    CrossrefPubMedGoogle Scholar
  • 15 Delitala G. Dopamine and TSH secretion in man.  The Lancet. 1977;  8 760-761
    PubMedGoogle Scholar
  • 16 Cooper D S, Klibanski A, Ridgway E C. Dopaminergic modulation of TSH and its subunits: In vivo and in vitro studies.  Clin Endocrinology. 1974;  16 265-275
    PubMedGoogle Scholar
  • 17 Refetoff S, Fang V S, Rapoport B, Friesen H G. Effect of L-dopa, TSH and thyroid hormone in various combinations.  J Clin Endocrinol Metab. 1983;  38 450-456
    PubMedGoogle Scholar
  • 18 Minozzi M, Faggiano M, Lombardi G. Carella C, Criscuolo T, Scapagnini U. Effect of L-Dopa on plasma TSH levels in primary hypothyroidism.  Neuroendocrinology. 1975;  17 147-153
    PubMedGoogle Scholar
  • 19 Scanlon M F, Weightman D R, Mora B, Heath M, Shale D J, Snow M H, Hall R. Evidence for dopaminergic control of thyrotropin secretion in man.  Lancet. 1977;  27 421-423
    PubMedGoogle Scholar
  • 20 Scanlon M F, Weightman D R, Shale D J, Mora B, Heath M, Snow M H, Lewis M, Hall R. Dopamine is a physiological Regulator of thyrotropin (TSH) secretion in normal man.  Clinical endocrinology. 1979;  10 7-15
    PubMedGoogle Scholar
  • 21 Pourmand N, Rodriguez-Arnao M D, Weightman D R, Hall R, Cook D B, Lewis M, Scanlon M F. Domperidone: A novel agent for the investigation of anterior pituitary function and control in man.  Clinical endocrinology. 1980;  12 211-215
    PubMedGoogle Scholar
  • 22 Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travalini P. Enhanced plasma thyrotropin response to thyrotropin releasing hormone following estradiol administration in man.  Clinical Endocrinology. 1973;  2 207-210
    PubMedGoogle Scholar
  • 23 Lloyd H M, Meares J D, Jacobi J. Early effects of stilboesterol on growth hormone and prolactin secretion and on mitotic activity in the male rat.  J of Endocrinology. 1973;  58 227-231
    PubMedGoogle Scholar
  • 24 Sowers J R, McCallum R W, Harshman J M, Sturdevant R AL, Meyer N. Comparison of metoclopramide with other dynamic tests of prolactin secretion.  J Clin Endocrinol Metab. 1976;  43 679-681
    PubMedGoogle Scholar
  • 25 Feek C M, Sawers J SA, Brown N S, Seth J, Irvine W J, Toft A D. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion.  J Clin Endocrinol Metab. 1980;  51 585-589
    PubMedGoogle Scholar
  • 26 Scanlon M F, Weetman A P, Lewis M, Pourmand M, Rodriguez-Arnao M D, Weightman D R, Hall R. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects.  J Clin Endocrinol Metab. 1980;  51 1251-1256
    PubMedGoogle Scholar
  • 27 Scanlon M F, Chan V, Health M, Pourmand M, Rodriguez-Arnao M D, Weightman O R, Lewis M, Hall R. Dopaminergic control of thyrotropin, α-subunit, β-subunits and prolactin in euthyroidism and hypothyroidism.  J Clin Endocrinol Metab. 1981;  58 360-365
    PubMedGoogle Scholar
  • 28 Spitz I M, Treslian S, Cohen H, Arnon N, Roith L D. Failure of metoclopramide to influence LH, FSH and TSH secretion or their responses to releasing hormones.  Acta Endocrinologica. 1979;  92 640-647
    PubMedGoogle Scholar
  • 29 Wayne F L, Louyse A L, Woolf P D. Dopamine affects basal and augmented pituitary Hormone Secretion.  J Clin Endocrinol Metab. 1978;  47 480-487
    PubMedGoogle Scholar
  • 30 Eddy R L, Jones A L, Chakmakjian H, Silverthorne M C. Effect of levadopa (L-DOPA) on human hypophyseal trophic hormone release.  J Clin Endocrinol Metab. 1971;  33 709-712
    PubMedGoogle Scholar

Dr. Anil Bhansali

Dept. of Endocrinology · Postgraduate Institute of Medical Education and Research ·

Chandigarh-160012 · India

Phone: + 91 (172) 74 75 85-600, ext. 65 83

Fax: + 91 (172) 74 44 01, 74 50 78 ·

Email: anilbhansali_endocrine@rediffmail.com

      >